Stock Comparison
ChemoMetec A/S vs Roche Holding AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ChemoMetec A/S
CHEMM · Nasdaq Copenhagen A/S
Weighted across the company's segments.
Full stock profile
Dive deeper into ChemoMetec A/S's moat claims, evidence, and risks.
View CHEMM analysisRoche Holding AG
ROP · SIX Swiss Exchange (participation certificate)
Weighted across the company's segments.
Full stock profile
Dive deeper into Roche Holding AG's moat claims, evidence, and risks.
View ROP analysisComparison highlights
- Moat score gap: ChemoMetec A/S leads (83 / 100 vs 69 / 100 for Roche Holding AG).
- Segment focus: ChemoMetec A/S has 2 segments (94.8% in Life science research, cell and gene therapy, and bioprocessing); Roche Holding AG has 2 segments (77.8% in Pharmaceuticals).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: ChemoMetec A/S has 3 moat types across 1 domains; Roche Holding AG has 3 across 2.
Primary market context
ChemoMetec A/S
Life science research, cell and gene therapy, and bioprocessing
Global cell counting and analysis instruments for LCB workflows
Global, skewed to USA/Canada and Europe
Pharmaceutical, biotech, cell and gene therapy, bioprocessing, and research labs
OEM instrument, consumables, software, and service provider
94.8%
Roche Holding AG
Pharmaceuticals
Innovative (branded) prescription pharmaceuticals
Global
Healthcare providers and systems (hospitals/clinics), payers/governments, and patients
Innovator pharmaceutical developer, manufacturer and marketer
77.8%
Side-by-side metrics
Moat coverage
Shared moat types
ChemoMetec A/S strengths
Roche Holding AG strengths
Segment mix
ChemoMetec A/S segments
Full profile >Life science research, cell and gene therapy, and bioprocessing
Oligopoly
Production control and quality control of animal semen, beer and milk
Oligopoly
Roche Holding AG segments
Full profile >Pharmaceuticals
Competitive
Diagnostics
Oligopoly
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.